305 related articles for article (PubMed ID: 16866910)
1. Oxysterols and Alzheimer's disease.
Björkhem I; Heverin M; Leoni V; Meaney S; Diczfalusy U
Acta Neurol Scand Suppl; 2006; 185():43-9. PubMed ID: 16866910
[TBL] [Abstract][Full Text] [Related]
2. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
3. Oxysterols and neurodegenerative diseases.
Björkhem I; Cedazo-Minguez A; Leoni V; Meaney S
Mol Aspects Med; 2009 Jun; 30(3):171-9. PubMed ID: 19248803
[TBL] [Abstract][Full Text] [Related]
4. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain.
Björkhem I
J Intern Med; 2006 Dec; 260(6):493-508. PubMed ID: 17116000
[TBL] [Abstract][Full Text] [Related]
5. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
Loera-Valencia R; Goikolea J; Parrado-Fernandez C; Merino-Serrais P; Maioli S
J Steroid Biochem Mol Biol; 2019 Jun; 190():104-114. PubMed ID: 30878503
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of 24S-hydroxycholesterol in neuronal SK-N-BE cells treated with hexacosanoic acid (C26:0): argument in favor of 24S-hydroxycholesterol as a potential biomarker of neurolipotoxicity.
Zarrouk A; Hammami M; Moreau T; Lizard G
Rev Neurol (Paris); 2015 Feb; 171(2):125-9. PubMed ID: 25577946
[TBL] [Abstract][Full Text] [Related]
7. The role of 24S-hydroxycholesterol in Alzheimer's disease.
Kölsch H; Lütjohann D; von Bergmann K; Heun R
J Nutr Health Aging; 2003; 7(1):37-41. PubMed ID: 12679839
[TBL] [Abstract][Full Text] [Related]
8. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease.
Heverin M; Bogdanovic N; Lütjohann D; Bayer T; Pikuleva I; Bretillon L; Diczfalusy U; Winblad B; Björkhem I
J Lipid Res; 2004 Jan; 45(1):186-93. PubMed ID: 14523054
[TBL] [Abstract][Full Text] [Related]
9. Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.
Gosselet F; Saint-Pol J; Fenart L
Biochem Biophys Res Commun; 2014 Apr; 446(3):687-91. PubMed ID: 24275140
[TBL] [Abstract][Full Text] [Related]
10. Oxysterol derivatives of cholesterol in neurodegenerative disorders.
Jeitner TM; Voloshyna I; Reiss AB
Curr Med Chem; 2011; 18(10):1515-25. PubMed ID: 21428891
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.
Lukiw WJ
Expert Rev Neurother; 2006 May; 6(5):683-93. PubMed ID: 16734516
[TBL] [Abstract][Full Text] [Related]
12. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls.
Schönknecht P; Lütjohann D; Pantel J; Bardenheuer H; Hartmann T; von Bergmann K; Beyreuther K; Schröder J
Neurosci Lett; 2002 May; 324(1):83-5. PubMed ID: 11983301
[TBL] [Abstract][Full Text] [Related]
14. On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review).
Björkhem I; Leoni V; Svenningsson P
J Steroid Biochem Mol Biol; 2019 Apr; 188():86-89. PubMed ID: 30586624
[TBL] [Abstract][Full Text] [Related]
15. Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain.
Heverin M; Meaney S; Lütjohann D; Diczfalusy U; Wahren J; Björkhem I
J Lipid Res; 2005 May; 46(5):1047-52. PubMed ID: 15741649
[TBL] [Abstract][Full Text] [Related]
16. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases.
Leoni V; Caccia C
Biochimie; 2013 Mar; 95(3):595-612. PubMed ID: 23041502
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation.
Björkhem I; Lütjohann D; Diczfalusy U; Ståhle L; Ahlborg G; Wahren J
J Lipid Res; 1998 Aug; 39(8):1594-600. PubMed ID: 9717719
[TBL] [Abstract][Full Text] [Related]
18. The Diagnostic Use of the Plasma Quantification of 24S-Hydroxycholesterol and Other Oxysterols in Neurodegenerative Disease.
Tripodi D; Vitarelli F; Spiti S; Leoni V
Adv Exp Med Biol; 2024; 1440():337-351. PubMed ID: 38036888
[TBL] [Abstract][Full Text] [Related]
19. Novel pathways for elimination of cholesterol by extrahepatic formation of side-chain oxidized oxysterols.
Diczfalusy U; Lund E; Lütjohann D; Björkhem I
Scand J Clin Lab Invest Suppl; 1996; 226():9-17. PubMed ID: 8981665
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol metabolism in the brain: importance of 24S-hydroxylation.
Lütjohann D
Acta Neurol Scand Suppl; 2006; 185():33-42. PubMed ID: 16866909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
